| Insurance Industry | Financials Sector | Dr. Marla Cindy Dubinsky M.D. CEO | LSE Exchange | GB00BNNFM402 ISIN |
| United States Country | 31 Employees | - Last Dividend | - Last Split | - IPO Date |
Trellus Health plc is a pioneering company dedicated to transforming the management of chronic conditions, with a specific focus on inflammatory bowel diseases such as Crohn's Disease and ulcerative colitis. Founded in 2020 and based in White Plains, New York, Trellus Health employs digital technology to enhance the way employers and health plans support individuals battling chronic diseases. The company is distinguished by its innovative approach to care, leveraging a proprietary technology platform named TrellusElevate, designed under strict HIPAA compliance to ensure privacy and security in telemedicine applications. Trellus Health's mission is to streamline the care process, making expert guidance and support readily accessible to patients, hence improving their quality of life and health outcomes.
A cornerstone of Trellus Health’s offerings, the TrellusElevate platform represents the fusion of technology and personalized healthcare. This HIPAA-compliant technology solution is engineered to remotely coordinate and deliver comprehensive care for individuals with chronic conditions, specifically targeting inflammatory bowel diseases. Through TrellusElevate, patients gain access to a tailored care team, ensuring a cohesive approach to managing their health. The platform facilitates telemedicine consultations, enabling patients to receive expert medical advice without the need for in-person visits. Furthermore, TrellusElevate enriches the patient experience with an array of educational content, aimed at empowering individuals with knowledge about their conditions and how best to manage them. Remote monitoring features are also integrated, allowing the care team to closely follow the patient’s health status and adjust treatment plans accordingly.